2021 articles
- Exercise as a treatment: do we talk about it enough in Hypertension Management? ( 19/11/2021 )
- The Impact of Poor Sleep on Atrial Fibrillation ( 18/11/2021 )
- AF screening and thromboembolic risk: How much AF is significant? ( 08/11/2021 )
- European Society of Cardiology Heart Failure Guidelines 2021: What should we be doing in current practice? ( 01/11/2021 )
- Heart failure with preserved ejection fraction ( 07/06/2021 )
- Utility of CT coronary angiography in non-ST elevation acute coronary syndrome ( 03/06/2021 )
- Sodium-glucose co-transporter 2 inhibitors – new frontier in the treatment of heart failure ( 03/06/2021 )
- Smartwatches: The New Way to Diagnose Arrhythmias? ( 18/05/2021 )
- Is it time for first line ablation in early paroxysmal AF? ( 06/05/2021 )
- Artificial Intelligence (AI) – potential benefits and challenges in Coronary Artery Disease – Focus on Diagnostic Imaging ( 26/04/2021 )
- Iron Therapy in Heart Failure – The Evidence So Far ( 26/04/2021 )
- Burnout ( 09/04/2021 )
- TWILIGHT – Is It Possible To Drop Aspirin Post PCI? ( 09/04/2021 )
- Omega-3 fatty acids and cardiovascular risk prevention ( 09/04/2021 )
- Risk screening in cardiovascular disease: the role of CT coronary angiography in asymptomatic patients, why wait? ( 13/03/2021 )
- Exploring a novel medical therapy for hypertrophic cardiomyopathy: EXPLORER-HCM and beyond ( 01/02/2021 )
- Soluble guanylate cyclase agonists: Have we found a new “new drug” for heart failure? ( 01/02/2021 )
- COVID-19: Impact on Cardiovascular Research ( 15/01/2021 )